Delivery Order SPE2DB20D3304-SPE2DB26FW4G7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $97,006.28 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets (90-count) under a firm fixed price contract. The award, issued on July 23, 2025, with completion by July 24, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.45 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 320-25 mg tablets (90-count units) under a firm fixed price arrangement. The contract was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, and does not utilize a set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $20,575.76 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) under a firm fixed price arrangement. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and is classified as a non-set-aside competitive procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diovan HCT 320-12.5 mg tablets (90-count supply) on September 29, 2025, with a ceiling value of $1,927.00 and completion deadline of September 30, 2025. This firm fixed-price delivery order is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle active...
- The Defense Logistics Agency awarded a delivery order valued at $9,967.16 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90-count) with a ceiling value of $17,047.43. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is due for completion by August 13, 2025. The award was executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) valued at $20,722.73 under a firm fixed-price contract with an ultimate completion date of August 26, 2025. The award, issued on August 25, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,090.39 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Diovan HCT 80-12.5 mg tablets (90-count bottles). This competitive award, issued without set-aside designation, utilizes firm fixed pricing and is scheduled for completion by August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Diovan HCT 80-12.5 mg tablets in a quantity of 90s, valued at $6,317.04 under a firm fixed-price contract structure. This non-set-aside delivery order, which is categorized as a child contract, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The award leverages...
- This is a $2,035.24 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Diovan HCT 320-12.5 mg tablets, a cardiovascular medication, with a performance period through December 2, 2022. The contract is a firm fixed price arrangement and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB26FW4G7Delivery Order
The Defense Logistics Agency has awarded a delivery order valued at $7,962.06 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 320-12.5 mg tablets (90-count), with an ultimate completion date of October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant IDC (SPE2DX) with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This comprehensive vehicle enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Diovan HCT represents a routine pharmaceutical fulfillment under this expansive prime vendor agreement, demonstrating the company's continued role as a critical supplier for federal medical procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 10/24/25 |